Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

HLS Therapeutics Inc T.HLS

Alternate Symbol(s):  HLTRF

HLS Therapeutics Inc. is a pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. It is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. It is also focused on products targeting the central nervous system and cardiovascular therapeutic areas. Its products include Clozaril, CSAN Pronto, MyCare Psychiatry and Vascepa. Its Clozaril is an atypical antipsychotic indicated for the management of symptoms of treatment-resistant schizophrenia for the Canadian and United States markets. CSAN Pronto is a capillary point-of-care medical device designed to enhance and simplify the mandatory safety blood monitoring process for patients that are prescribed Clozaril. The Vascepa (icosapent ethyl capsules) is a single-molecule prescription product in use to reduce the risk of cardiovascular events.


TSX:HLS - Post by User

Bullboard Posts
Post by fairweather1on Apr 22, 2013 1:17pm
208 Views
Post# 21289566

ontario budget may 2

ontario budget may 2

Ontario budget is to be presented May 2. 

I know this board has seen lots of discussion of the 150M tech funding.  I don't pretend to understand fully the domino effect of how this will help AM, but from what I hear, the optimistic theory is as follows:

  • tech innovation (?) fund is topped up by $150M
  • ford can tap into this to remain competitive in Canada, and makes big infrastructure investments
  • AM is given a new contract for at least several years

Correct in theory?

If so, how fast would these dominoes fall?  I am thinking the fund top up would be immediate.  The Ford infrastructure plan timing is an unknown.  The AM contract decision should be right after or concurrent with the infrastructure announcement, since it has been stated by AM (and is intuitive), that you need a substantial lead time to retool for this kind of work.

So do we have any clues as to how fast Ford will announce its infrastructure decisions?  For instance, has a precedent been set in similar circumstances before when Ford was holding out for government funding?  While a different situation, it was interesting to see how fast Ford moved on the labour front last year.  It seemed they had a plan/mandate that left GM & Chrysler looking like they were just winging it.

Bullboard Posts